BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20848095)

  • 1. Control of the specificity of T cell-mediated anti-idiotype immunity by natural regulatory T cells.
    Warncke M; Buchner M; Thaller G; Dodero A; Bulashevska A; Pfeifer D; Timmer J; Veelken H
    Cancer Immunol Immunother; 2011 Jan; 60(1):49-60. PubMed ID: 20848095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
    J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rejection of tumors of the B cell lineage by idiotype-vaccinated mice.
    Haimovich J; Kukulansky T; Weissman B; Hollander N
    Cancer Immunol Immunother; 1999 Feb; 47(6):330-6. PubMed ID: 10203063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upfront immunization with autologous recombinant idiotype Fab fragment without prior cytoreduction in indolent B-cell lymphoma.
    Navarrete MA; Heining-Mikesch K; Schüler F; Bertinetti-Lapatki C; Ihorst G; Keppler-Hafkemeyer A; Dölken G; Veelken H
    Blood; 2011 Feb; 117(5):1483-91. PubMed ID: 21045197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies.
    Cesco-Gaspere M; Benvenuti F; Burrone OR
    Cancer Immunol Immunother; 2005 Apr; 54(4):351-8. PubMed ID: 15692846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of predicted HLA binding of immunoglobulin idiotype sequences indicates T cell-mediated immunosurveillance in follicular lymphoma.
    Strothmeyer AM; Papaioannou D; Dühren-von Minden M; Navarrete M; Zirlik K; Heining-Mikesch K; Veelken H
    Blood; 2010 Sep; 116(10):1734-6. PubMed ID: 20522710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of a novel intradermal idiotype vaccine in patients with advanced B-cell lymphoma: specific immune responses despite profound immunosuppression.
    Bertinetti C; Zirlik K; Heining-Mikesch K; Ihorst G; Dierbach H; Waller CF; Veelken H
    Cancer Res; 2006 Apr; 66(8):4496-502. PubMed ID: 16618777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H-2-linked Ir gene control of VH determinant(s)-specific helper T cells.
    Kawahara DJ; Marrack P; Kappler JW
    J Mol Cell Immunol; 1986; 2(5):255-64. PubMed ID: 2978232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen- and receptor-driven regulatory mechanisms. V. The failure of idiotype-coupled spleen cells to induce unresponsiveness in animals lacking the appropriate VH genes is caused by the lack of idiotype-matched targets.
    Sy MS; Dietz MH; Nisonoff A; Germain RN; Benacerraf B; Greene MI
    J Exp Med; 1980 Nov; 152(5):1226-35. PubMed ID: 6159446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of established tumors in a novel murine model transgenic for human carcinoembryonic antigen and HLA-A2 with a combination of anti-idiotype vaccine and CTL peptides of carcinoembryonic antigen.
    Saha A; Chatterjee SK; Foon KA; Celis E; Bhattacharya-Chatterjee M
    Cancer Res; 2007 Mar; 67(6):2881-92. PubMed ID: 17363612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of anti-idiotypic suppressor T cells (Tsid) induced after antigen priming.
    Sherr DH; Dorf ME
    J Immunol; 1984 Sep; 133(3):1142-50. PubMed ID: 6205068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient induction of CD25- iTreg by co-immunization requires strongly antigenic epitopes for T cells.
    Geng S; Yu Y; Kang Y; Pavlakis G; Jin H; Li J; Hu Y; Hu W; Wang S; Wang B
    BMC Immunol; 2011 May; 12():27. PubMed ID: 21542943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T cells from (New Zealand Black x New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3.
    Fournel S; Neichel S; Dali H; Farci S; Maillère B; Briand JP; Muller S
    J Immunol; 2003 Jul; 171(2):636-44. PubMed ID: 12847228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes.
    Schirmbeck R; Stober D; El-Kholy S; Riedl P; Reimann J
    J Immunol; 2002 Jun; 168(12):6253-62. PubMed ID: 12055239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
    Curti A; Tosi P; Comoli P; Terragna C; Ferri E; Cellini C; Massaia M; D'Addio A; Giudice V; Di Bello C; Cavo M; Conte R; Gugliotta G; Baccarani M; Lemoli RM
    Br J Haematol; 2007 Nov; 139(3):415-24. PubMed ID: 17910631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growth.
    Bohlen H; Thielemanns K; Tesch H; Engert A; Wolf HJ; van Camp B; Urbain J; Diehl V
    Cytokines Mol Ther; 1996 Dec; 2(4):231-8. PubMed ID: 9384709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas.
    Betting DJ; Kafi K; Abdollahi-Fard A; Hurvitz SA; Timmerman JM
    J Immunol; 2008 Sep; 181(6):4131-40. PubMed ID: 18768870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
    Kwak LW; Young HA; Pennington RW; Weeks SD
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10972-7. PubMed ID: 8855293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W; Cui H; Chang XH; Cheng HY; Cheng YX; Feng J; Fu TY
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):764-9. PubMed ID: 19087545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.